'Primary efficacy analysis' presentation slideshows

Vaccines and Related Biological Drug Products Advisory Committee Meeting December 14, 2005

940 views • 72 slides

Atrasentan For Men with Metastatic Hormone Refractory Prostate Cancer ODAC September 13 th , 2005

Atrasentan For Men with Metastatic Hormone Refractory Prostate Cancer ODAC September 13 th , 2005. Clinical-Statistical Presentation Amna Ibrahim MD Shenghui Tang PhD DDOP, FDA. Outline of Presentation. 1- Past approvals 2- Phase III study Study design

791 views • 56 slides

ACS is a major public health challenge

353 views • 18 slides

ROCKET-AF

ROCKET-AF. Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation. NEJM 16 th August 2011. Raj Chahal 23/08/2011.

593 views • 18 slides

337 views • 13 slides

MONET - Trial Design

The MONET trial 96 week analysis: darunavir/r monotherapy versus darunavir/r + 2NRTIs, for patients with HIV RNA < 50 copies/mL at baseline. Armin Rieger, Denes Banhegyi, Wolfgang Schmidt, Jose Arribas, Andrew Hill, Yvonne Van Delft, Christiane Moecklinghoff

233 views • 11 slides